← Back to Search

Dietary Supplement

Maqui berry extract and omega-3 fatty acids for Inflammation

N/A
Waitlist Available
Research Sponsored by Arizona State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline at day 56
Awards & highlights

Study Summary

This trial tests if maqui extract plus omega-3 can reduce inflammation in older, obese adults better than a placebo.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline at day 56
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline at day 56 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Interleukin-1 beta (IL-1 beta)
Interleukin-6 (IL-6)
Tumor Necrosis Factor (TNF)
Secondary outcome measures
Arachidonic acid (AA)
Eicosapentaenoic acid

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Maqui berry extract and omega-3 fatty acidsExperimental Treatment1 Intervention
2 capsules BID per day containing a total of 600 mg of Maqui extract; 4 capsules per day supplying a total of 2000 mg EPA and 1000 mg DHA
Group II: ControlPlacebo Group1 Intervention
4 olive oil soft gelatin capsules and inert two-piece capsules containing maltodextrin
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Maqui berry/omeg-3 fatty acids
2022
N/A
~40

Find a Location

Who is running the clinical trial?

Arizona State UniversityLead Sponsor
283 Previous Clinical Trials
109,482 Total Patients Enrolled
5 Trials studying Inflammation
463 Patients Enrolled for Inflammation

Media Library

Maqui berry/omega-3 fatty acids (Dietary Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT04914312 — N/A
Inflammation Research Study Groups: Maqui berry extract and omega-3 fatty acids, Control
Inflammation Clinical Trial 2023: Maqui berry/omega-3 fatty acids Highlights & Side Effects. Trial Name: NCT04914312 — N/A
Maqui berry/omega-3 fatty acids (Dietary Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04914312 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Maqui Berry Extract and Omega-3 Fatty Acids for Cytokine Reduction
Carol Johnston 2022. "Maqui Berry Extract and Omega-3 Fatty Acids for Cytokine Reduction". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04914312.
~10 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top